HHLR ADVISORS LTD. 13D and 13G filings for CHINA BIOLOGIC PRODS HLDGS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-22 09:15 am Sale | 2021-04-20 | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR ADVISORS LTD. | 0 0.000% | -2,962,076 (Position Closed) | Filing |
| 2020-11-23 09:00 am Unchanged | 2020-11-19 | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR ADVISORS LTD. | 2,962,076 7.600% | 0 (Unchanged) | Filing |
| 2020-10-28 4:00 pm Unchanged | 2020-10-26 | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR ADVISORS LTD. | 2,962,076 7.700% | 0 (Unchanged) | Filing |
| 2020-09-18 08:16 am Unchanged | 2020-09-16 | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR ADVISORS LTD. | 2,962,076 7.700% | 0 (Unchanged) | Filing |
| 2020-05-08 4:30 pm Unchanged | 2020-05-06 | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR ADVISORS LTD. | 2,962,076 7.700% | 0 (Unchanged) | Filing |